Is it appropriate to prescribe EzPAP (EzPAP device) for all residents in a skilled‑nursing or long‑term‑care facility as a blanket preventive measure regardless of diagnosis, and can it be billed under Medicare Part A?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blanket EzPAP Prescribing in Long-Term Care is Not Appropriate and Likely Constitutes Billing Fraud

Prescribing EzPAP (or any positive airway pressure device) to all residents in a skilled nursing or long-term care facility as a blanket preventive measure, regardless of diagnosis or clinical indication, is clinically inappropriate and potentially fraudulent billing practice. This approach violates fundamental principles of evidence-based medicine and Medicare billing requirements.

Why This Practice is Problematic

Clinical Inappropriateness

Positive airway pressure devices like EzPAP require specific clinical indications. The available guidelines consistently demonstrate that PAP therapy (including devices generating positive expiratory pressure) should only be used when there is:

  • A documented diagnosis requiring such therapy (e.g., obstructive sleep apnea, chronic alveolar hypoventilation, acute hypoxemic respiratory failure) 1, 2
  • Specific physiological abnormalities that the device is intended to correct 3
  • Clear therapeutic goals with measurable outcomes 4, 5

The recent research on EzPAP shows it increases tidal volume and airway pressures in controlled settings 6, 7, but these studies were conducted in patients with specific clinical indications (e.g., atelectasis, hypercapnic COPD exacerbations, postoperative hypoxemia) 7, 8, 9, 10—not as blanket prevention in asymptomatic individuals.

Medicare Billing Requirements

Medicare Part A reimbursement requires medical necessity. To bill Medicare for respiratory therapy treatments, facilities must document:

  • A physician order based on a specific diagnosis
  • Clinical justification for the intervention
  • Expected therapeutic benefit
  • Ongoing assessment of treatment effectiveness

Ordering treatments on "every single resident" without individualized clinical assessment fails to meet the medical necessity standard required for Medicare reimbursement. This practice pattern—particularly when driven by someone who "found a way to bill Medicare"—raises serious red flags for:

  • False Claims Act violations: Billing for medically unnecessary services
  • Fraud and abuse: Systematic billing for services without proper indication
  • Stark Law concerns: If there are financial relationships driving inappropriate utilization

What the Evidence Actually Supports

Legitimate Uses of Positive Expiratory Pressure Devices

The evidence supports EzPAP and similar devices for:

  1. Postoperative atelectasis prevention in high-risk surgical patients 9, 10
  2. Treatment of documented hypoxemia with radiological atelectasis 7
  3. Hypercapnic COPD exacerbations as an alternative to NIV 8
  4. Specific lung expansion therapy in patients with reduced lung volumes 6

What is NOT Supported

There is zero evidence supporting:

  • Blanket use in all long-term care residents regardless of diagnosis
  • Preventive use in asymptomatic individuals without respiratory pathology
  • "Wellness programs" involving respiratory devices in patients without respiratory disease

Red Flags in Your Situation

The scenario you describe contains multiple concerning elements:

  1. Universal ordering without clinical assessment: Ordering on "every single resident" regardless of diagnosis violates basic medical practice standards
  2. Corporate-driven "wellness program" spin: Using wellness terminology to justify medically unnecessary treatments
  3. Billing-driven decision making: The admission that someone "found a way to bill Medicare" suggests financial motivation rather than clinical need
  4. Acapella device inclusion: Adding airway clearance devices (Acapella) to patients without secretion clearance needs further suggests inappropriate utilization

What Should Happen Instead

Appropriate respiratory therapy ordering requires:

  • Individual clinical assessment by a physician or qualified practitioner
  • Documented diagnosis requiring the specific intervention
  • Clear therapeutic goals (e.g., improve oxygenation, reduce atelectasis, facilitate secretion clearance)
  • Ongoing monitoring and documentation of treatment response
  • Discontinuation when no longer medically necessary

For long-term care residents, legitimate indications might include:

  • Documented obstructive sleep apnea requiring PAP therapy 11
  • Chronic respiratory failure from neuromuscular disease or chest wall deformity 3, 2
  • Acute respiratory conditions requiring temporary support 4

Your Concerns are Justified

This practice pattern appears to prioritize revenue generation over patient care and medical necessity. If you are a healthcare provider in this facility, you should:

  • Document your concerns through appropriate channels
  • Refuse to participate in ordering treatments without clinical indication
  • Consider reporting to compliance officers or regulatory authorities if the practice continues

The corporate justification as a "wellness program" does not override Medicare requirements for medical necessity, and systematic billing for medically unnecessary services constitutes fraud regardless of how it is marketed internally.

References

Guideline

clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (nppv) in stable chronic alveolar hypoventilation syndromes.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Guideline

treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2019

Research

Effect of the EzPAP system on tidal volume and airway pressures in healthy adults.

Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR, 2026

Guideline

evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Related Questions

Is the EzPAP (positive airway pressure) system an effective preventive treatment for all residents in skilled‑nursing or long‑term‑care facilities regardless of diagnosis?
Does the medical literature support the use of the EzPAP (positive airway pressure) system to improve lung expansion and prevent adverse clinical outcomes or exacerbations of comorbidities?
In which diseases is EzPAP (positive airway pressure for airway clearance) indicated, and should it be used alone or is it more effective when combined with short‑acting bronchodilators such as albuterol or ipratropium?
Is requiring incentive spirometry, EzPAP (positive airway pressure device), and Acapella (airway clearance device) for all patients breathing room air without a history of respiratory disease medically justified, or could it constitute Medicare fraud?
Should incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory airway clearance device) be used routinely for a general skilled nursing facility or long‑term care patient population who are breathing room air, have no history of pulmonary disease, and are only limited by reduced activity?
When does a corrected QT interval (QTc) become clinically significant?
What is the best malaria chemoprophylaxis regimen for a 27-year-old male soldier with well-controlled depression deploying to the southern border of Saudi Arabia?
Does diphenhydramine cause QTc prolongation?
Can my bladder cancer (non‑invasive or invasive) affect my appetite while awaiting pathology results?
What is the elimination half‑life of venlafaxine 25 mg and how long does it take for the drug and its active metabolite to be cleared from the body?
What is the recommended dose of doxofylline for adult patients with conditions such as chronic obstructive pulmonary disease, asthma, or bronchospasm?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.